2022
DOI: 10.3389/fpubh.2022.883066
|View full text |Cite
|
Sign up to set email alerts
|

As Omicron Takes Hold and Other New Variants Arise, COVID-19 Testing Remains the Universally Agreed Tool to Effect Transition From Pandemic to Endemic State

Abstract: The COVID-19 pandemic has caused more than 448 million cases and 6 million deaths worldwide to date. Omicron is now the dominant SARS-CoV-2 variant, making up more than 90% of cases in countries reporting sequencing data. As the pandemic continues into its third year, continued testing is a strategic and necessary tool for transitioning to an endemic state of COVID-19. Here, we address three critical topics pertaining to the transition from pandemic to endemic: defining the endemic state for COVID-19, highligh… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 13 publications
0
3
0
Order By: Relevance
“…Additionally, there were recommendations to delay doses at least 3 months after SARS-CoV-2 infection. 38 While SARS-CoV-2 polymerase chain reaction testing in Ontario was limited due to overwhelming case volumes after November 2021, 39 , 40 surveillance studies from other Canadian jurisdictions suggest high pediatric infection rates during that time. 41 …”
Section: Methodsmentioning
confidence: 99%
“…Additionally, there were recommendations to delay doses at least 3 months after SARS-CoV-2 infection. 38 While SARS-CoV-2 polymerase chain reaction testing in Ontario was limited due to overwhelming case volumes after November 2021, 39 , 40 surveillance studies from other Canadian jurisdictions suggest high pediatric infection rates during that time. 41 …”
Section: Methodsmentioning
confidence: 99%
“…However, the following cases may be missed by syndromic surveillance: patients with early stage of the disease, mild infections, atypical symptoms, co-morbidities, extreme age, co-infections, uncommon routes of transmission, and infections from various virus variants. 30 , 50 With the advance in science and technology of viral kinetics of SARS-CoV-2, laboratory testing plays a key role in early case finding (including symptomatic, pre-symptomatic, and asymptomatic patients) and guiding risk-adjusted and transmission-based IPC measures. The national laboratory network was established and strengthened through the recruitment of medical centers and regional hospitals distributed throughout most geographical regions of the country in January 2020; later, the network expanded the available testing supply and maximized testing capacity.…”
Section: Sars-cov-2 Pcr Testing Strategiesmentioning
confidence: 99%
“…SARS-CoV-2 surveillance began with individual-based testing early in the pandemic, using reverse transcription real-time polymerase chain reaction (RT-qPCR) to detect viral RNA from nasopharyngeal swabs samples ( 11 , 12 ). Other screening methods have also been employed, such as thermography, antigen rapid tests (ART), and volatile organic compound detection ( 12 ).…”
Section: Introductionmentioning
confidence: 99%